KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Change in Cash (2016 - 2025)

Historic Change in Cash for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to -$2.5 billion.

  • Eli Lilly's Change in Cash fell 238865.88% to -$2.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.0 billion, marking a year-over-year increase of 79086.86%. This contributed to the annual value of $4.0 billion for FY2025, which is 79086.86% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Change in Cash is -$2.5 billion, which was down 238865.88% from $6.4 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Change in Cash registered a high of $6.4 billion during Q3 2025, and its lowest value of -$2.5 billion during Q4 2025.
  • Its 5-year average for Change in Cash is $180.5 million, with a median of $12.4 million in 2021.
  • Per our database at Business Quant, Eli Lilly's Change in Cash tumbled by 560363.64% in 2023 and then skyrocketed by 431265.47% in 2025.
  • Over the past 5 years, Eli Lilly's Change in Cash (Quarter) stood at $30.3 million in 2021, then crashed by 1916.5% to -$550.4 million in 2022, then surged by 179.61% to $438.2 million in 2023, then tumbled by 123.14% to -$101.4 million in 2024, then tumbled by 2388.66% to -$2.5 billion in 2025.
  • Its last three reported values are -$2.5 billion in Q4 2025, $6.4 billion for Q3 2025, and $282.6 million during Q2 2025.